Albert Louis Pisani, MD
Gynecological Oncology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 6
- 3 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
6 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pisani’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
6 of 6 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G67056 · Current
Licensed to practise in California · since 1989 · expires 2027-08-31 · Northwestern University Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$87,233
Medicare paid this office $87,233 for 168 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 16 | $12,167 | $760 |
| Return visit (30+ min) | 63 | $9,309 | $118 |
| Short return visit (20+ min) | 78 | $6,684 | $73 |
| New patient visit (60+ min) | 32 | $6,257 | $196 |
| Long return visit (40+ min) | 25 | $5,554 | $174 |
See all 7 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 16 | $12,167 | $760 |
| Return visit (30+ min) | 63 | $9,309 | $118 |
| Short return visit (20+ min) | 78 | $6,684 | $73 |
| New patient visit (60+ min) | 32 | $6,257 | $196 |
| Long return visit (40+ min) | 25 | $5,554 | $174 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 14 | $4,178 | $298 |
| Imaging of lymph nodes during surgery | 22 | $2,784 | $127 |
Procedures Medicare counted
| Colonoscopy | 1-10 | None |
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of the uterus | 24 | More than 95% of doctors who do this |
Who their Medicare patients are
168 Original Medicare patients in 2024. Average age 75 · Women 100% · Health risk score 1.06. At or below the middle of the specialty; the typical gynecological oncology clinician is at 1.53.
Conditions among them: High blood pressure 65% · Cancer 58% · Coronary heart disease 17% · Chronic kidney disease 17% · Diabetes 15% · Depression 14% · Atrial fibrillation 9% · Heart failure 8% · COPD 7%.
The office billed $401,795, Medicare allowed $112,677 and paid $87,233; for 593 services of 62 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 168 | 593 | 75 | 1.06 | $401,795 | $87,233 |
| 2023 | 163 | 346 | 75 | 1.16 | $318,637 | $68,465 |
| 2022 | 155 | 311 | 75 | 1.23 | $247,954 | $58,204 |
| 2021 | 202 | 545 | 74 | 1.36 | $515,626 | $121,616 |
| 2020 | 180 | 529 | 73 | 1.32 | $551,091 | $123,200 |
| 2019 | 226 | 613 | 73 | 1.26 | $646,315 | $136,620 |
| 2018 | 197 | 545 | 72 | 1.27 | $618,030 | $122,961 |
| 2017 | 195 | 574 | 73 | 1.16 | $686,425 | $141,183 |
| 2016 | 179 | 567 | 72 | 1.24 | $656,604 | $139,357 |
| 2015 | 156 | 858 | 74 | 1.28 | $716,116 | $163,239 |
| 2014 | 172 | 534 | 73 | 1.11 | $585,514 | $137,635 |
| 2013 | 169 | 511 | 73 | 1.27 | $636,122 | $152,644 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 88 | $8,108 | $78 |
| New patient visit (60+ min) | 36 | $7,626 | $212 |
| Return visit (30+ min) | 37 | $5,173 | $115 |
| Long return visit (40+ min) | 18 | $3,487 | $174 |
2022: 5 services
| Short return visit (20+ min) | 83 | $6,895 | $67 |
| New patient visit (60+ min) | 31 | $6,250 | $202 |
| Return visit (30+ min) | 36 | $4,624 | $113 |
| Long return visit (40+ min) | 13 | $2,282 | $176 |
| Imaging of lymph nodes during surgery | 12 | $1,949 | $162 |
2021: 8 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 23 | $18,037 | $784 |
| New patient visit (60+ min) | 59 | $12,309 | $209 |
| Short return visit (20+ min) | 106 | $10,985 | $80 |
| Return visit (30+ min) | 43 | $6,159 | $121 |
| Long return visit (40+ min) | 22 | $4,979 | $172 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 14 | $4,325 | $309 |
| Imaging of lymph nodes during surgery | 25 | $4,258 | $170 |
| Stool analysis for blood to screen for colon tumors | 28 | $123 | $4 |
2020: 9 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 30 | $24,423 | $814 |
| New patient visit (60+ min) | 58 | $10,921 | $188 |
| Short return visit (20+ min) | 95 | $7,836 | $65 |
| Return visit (30+ min) | 48 | $5,767 | $101 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 17 | $5,345 | $314 |
| Imaging of lymph nodes during surgery | 21 | $3,654 | $174 |
| Long return visit (40+ min) | 15 | $2,716 | $143 |
| Biopsy of lining of uterus | 12 | $1,152 | $89 |
| Stool analysis for blood to screen for colon tumors | 14 | $61 | $4 |
2019: 9 services
| New patient visit (60+ min) | 69 | $12,836 | $186 |
| Short return visit (20+ min) | 127 | $10,886 | $63 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 15 | $10,097 | $673 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 15 | $7,774 | $518 |
| Return visit (30+ min) | 44 | $5,447 | $97 |
| Removal of ovaries and/or tubes using an endoscope | 12 | $5,049 | $421 |
| Imaging of lymph nodes during surgery | 21 | $3,780 | $180 |
| Long return visit (40+ min) | 21 | $3,062 | $133 |
| Removal of appendix during other major procedure | 12 | $889 | $74 |
2018: 7 services
| New patient visit (60+ min) | 70 | $12,200 | $174 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 12 | $8,184 | $682 |
| Short return visit (20+ min) | 90 | $7,404 | $64 |
| Return visit (30+ min) | 59 | $6,722 | $90 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 11 | $5,790 | $526 |
| Long return visit (40+ min) | 16 | $2,456 | $136 |
| Diagnostic exam of bladder and urethra using an endoscope | 16 | $597 | $37 |
2017: 10 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 19 | $19,412 | $1,022 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 24 | $14,953 | $623 |
| New patient visit (60+ min) | 76 | $14,129 | $186 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 15 | $10,398 | $693 |
| Short return visit (20+ min) | 89 | $6,805 | $59 |
| Return visit (30+ min) | 48 | $5,626 | $95 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 13 | $3,925 | $302 |
| Long return visit (40+ min) | 13 | $1,760 | $135 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $718 | $51 |
| Injection of radioactive material for x-ray identification of lymph node | 32 | $608 | $19 |
2016: 9 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 18 | $19,077 | $1,060 |
| New patient visit (60+ min) | 70 | $12,797 | $183 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 13 | $8,829 | $679 |
| Short return visit (20+ min) | 79 | $6,631 | $59 |
| Return visit (30+ min) | 51 | $6,150 | $92 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 12 | $5,758 | $480 |
| Long return visit (40+ min) | 12 | $1,620 | $125 |
| Removal of appendix during other major procedure | 12 | $867 | $72 |
| Diagnostic exam of bladder and urethra using an endoscope | 11 | $687 | $57 |
2015: 13 services
| Removal of lining of abdomen, uterus, ovaries, fallopian tubes, and lymph nodes of pelvis and aorta for reduction of growth | 12 | $22,522 | $1,877 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 13 | $14,567 | $1,121 |
| New patient visit (60+ min) | 58 | $11,059 | $191 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 11 | $7,915 | $720 |
| Short return visit (20+ min) | 77 | $6,321 | $63 |
| Removal of lymph nodes of both sides of pelvis and abdominal lymph node biopsy using an endoscope | 11 | $5,904 | $537 |
| Return visit (30+ min) | 29 | $4,031 | $98 |
| Insertion of central venous tube with port (5 years or older) | 12 | $3,987 | $332 |
| Long return visit (40+ min) | 12 | $1,602 | $123 |
| Removal of appendix during other major procedure | 13 | $982 | $76 |
| Diagnostic exam of bladder and urethra using an endoscope | 14 | $840 | $60 |
| Review by radiologist of major upper body vein image | 12 | $613 | $51 |
| Diagnostic exam of rectum and lower large bowel using an endoscope | 11 | $288 | $26 |
2014: 7 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 16 | $19,202 | $1,200 |
| New patient visit (60+ min) | 70 | $12,645 | $181 |
| Return visit (30+ min) | 53 | $5,876 | $89 |
| Short return visit (20+ min) | 67 | $5,256 | $58 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 11 | $4,500 | $409 |
| Insertion of stent in ureter using an endoscope | 11 | $1,713 | $132 |
| Biopsy of lining of uterus | 13 | $1,263 | $97 |
2013: 9 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, more than 250.0 g | 21 | $25,050 | $1,193 |
| New patient visit (60+ min) | 64 | $11,361 | $178 |
| Surgical repair of vaginal defect using an endoscope | 12 | $9,034 | $753 |
| Plastic repair of vagina and tissue separating vagina, rectum, and bladder | 13 | $5,176 | $398 |
| Short return visit (20+ min) | 57 | $4,846 | $64 |
| Return visit (30+ min) | 42 | $4,728 | $91 |
| Removal of ovaries and/or tubes using an endoscope | 11 | $3,700 | $336 |
| Long return visit (40+ min) | 19 | $2,945 | $128 |
| Biopsy of lining of uterus | 17 | $1,722 | $101 |
Drugs they prescribed that Part D paid
$3,972
Pharmacies billed $3,972 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
73 generic and 11 brand-name prescriptions · $3,972 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Letrozole | 17 | $433 | $25 |
Year by year
| 2024 | 84 | 33 | None | 13% | $3,972 |
| 2023 | 79 | 25 | 0% (0) | 18% | $3,373 |
| 2022 | 62 | 28 | 0% (0) | None | $2,120 |
| 2021 | 122 | 34 | None | 16% | $128,535 |
| 2020 | 137 | 45 | None | 15% | $95,372 |
| 2019 | 88 | 34 | 0% (0) | None | $4,143 |
| 2018 | 129 | 37 | None | 10% | $6,124 |
| 2017 | 106 | 45 | 10% (11) | 12% | $3,232 |
| 2016 | 120 | 45 | 11% (13) | 9% | $16,089 |
| 2015 | 121 | 58 | None | 29% | $8,009 |
| 2014 | 121 | 64 | 29% (35) | 23% | $5,317 |
| 2013 | 100 | 56 | 12% (12) | None | $12,760 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Letrozole | 17 | $300 | $18 |
| Amlodipine Besylate | 12 | $142 | $12 |
2022: 1 drug
| Letrozole | 12 | $493 | $41 |
2021: 3 drugs
| Lynparza | 17 | $125,920 | $7,407 |
| Letrozole | 23 | $701 | $30 |
| Amlodipine Besylate | 15 | $106 | $7 |
2020: 4 drugs
| Letrozole | 12 | $567 | $47 |
| Dexamethasone | 24 | $367 | $15 |
| Ondansetron | 19 | $260 | $14 |
| Prochlorperazine Maleate | 15 | $138 | $9 |
2019: 1 drug
| Letrozole | 18 | $346 | $19 |
2018: 4 drugs
| Letrozole | 24 | $318 | $13 |
| Dexamethasone | 11 | $262 | $24 |
| Ondansetron | 16 | $133 | $8 |
| Prochlorperazine Maleate | 24 | $115 | $5 |
2017: 1 drug
| Letrozole | 15 | $107 | $7 |
2016: 2 drugs
| Prochlorperazine Maleate | 11 | $77 | $7 |
| Lorazepam | 17 | $60 | $4 |
2015: 1 drug
| Suprep | 29 | $2,342 | $81 |
2014: 2 drugs
| Suprep | 20 | $1,565 | $78 |
| Hydrocodone-Acetaminophen | 33 | $336 | $10 |
2013: 4 drugs
| Premarin | 11 | $1,796 | $163 |
| Moviprep | 14 | $982 | $70 |
| Hydrocodone-Acetaminophen | 11 | $116 | $11 |
| Fluconazole | 11 | $43 | $4 |
Money from drug and device companies
$1,518 in 2025
| 2025 | 6 | 7 | $840 | $1,518 |
| 2024 | 5 | 15 | None | $3,435 |
| 2023 | 2 | 4 | None | $1,654 |
| 2022 | 5 | 12 | None | $1,303 |
| 2021 | 2 | 2 | None | $138 |
| 2020 | 9 | 9 | None | $384 |
| 2019 | 18 | 50 | None | $2,092 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genmab U.S. | Epkinly | $840 | 1 payment
|
| On Target Laboratories | Cytalux | $220 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $196 | 2 payments
|
| Eisai | Lenvima | $124 | 1 payment
|
| Myriad Genetic Laboratories | Precisetumor | $120 | 1 payment
|
| Baxter Healthcare | Floseal | $18 | 1 payment
|
See all 7 published payments
| Genmab U.S. | Consulting · 2025-12-05 | Epkinly | $840 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-17 | Lynparza | $125 |
| Myriad Genetic Laboratories | Meals · 2025-04-29 | Precisetumor | $120 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-15 | Lynparza | $71 |
| Eisai | Meals · 2025-03-14 | Lenvima | $124 |
| Baxter Healthcare | Meals · 2025-03-03 | Floseal | $18 |
| On Target Laboratories | Meals · 2025-02-24 | Cytalux | $220 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,435
| Intuitive Surgical | Da Vinci Surgical System | $2,837 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $208 | 4 payments
|
| Myriad Genetic Laboratories | Myrisk | $143 | 1 payment
|
| Pfizer | Tivdak | $125 | 1 payment
|
| GlaxoSmithKline | Zejula | $122 | 1 payment
|
2023: $1,654
| Intuitive Surgical | Da Vinci Surgical System | $1,574 | 3 payments
|
| Myriad Genetic Laboratories | Precisetumor | $80 | 1 payment
|
2022: $1,303
| Conmed | Airseal | $628 | 6 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $302 | 3 payments
|
| Seagen | Tivdak | $136 | 1 payment
|
| Myriad Genetic Laboratories | Mychoice Cdx | $123 | 1 payment
|
| GlaxoSmithKline | Zejula | $114 | 1 payment
|
2021: $138
| Heron Therapeutics | Zynrelef | $123 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $15 | 1 payment
|
2020: $384
| Merck Sharp & Dohme | Keytruda | $125 | 1 payment
|
| Baxter Healthcare | Adept | $122 | 1 payment
|
| Seagen | Adcetris | $30 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $22 | 1 payment
|
| Novartis Pharmaceuticals | Tasigna | $20 | 1 payment
|
| Janssen Biotech | Darzalex | $18 | 1 payment
|
| Celgene | Pomalyst | $17 | 1 payment
|
| Foundation Medicine | Foundationone | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Imfinzi | $15 | 1 payment
|
2019: $2,092
| Intuitive Surgical | Da Vinci Surgical System | $691 | 7 payments
|
| Tesaro | Zejula | $337 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $160 | 3 payments
|
| Clovis Oncology | Rubraca | $137 | 2 payments
|
| Genentech USA | Avastin | $102 | 1 payment
|
| Lilly USA | Alimta | $95 | 5 payments
|
| Novartis Pharmaceuticals | Votrient | $92 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $88 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Xofigo | $57 | 3 payments
|
| Janssen Biotech | Erleada | $54 | 2 payments
|
| Amgen | Nplate | $53 | 2 payments
|
| Merck Sharp & Dohme | Keytruda | $52 | 3 payments
|
| Celgene | Revlimid | $49 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Empliciti | $49 | 3 payments
|
| Rigel Pharmaceuticals | Tavalisse | $26 | 1 payment
|
| Incyte | Jakafi | $22 | 1 payment
|
| Eisai | Halaven | $16 | 1 payment
|
| Foundation Medicine | Foundationone | $13 | 1 payment
|
Professional record
- NPI
- 1295894673
- Licence
- CA G67056California G67056: Current · expires 2027-08-31
- Trained
- Northwestern University Feinberg Medical School, 1988
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VX0201X (207VX0201X); Federal specialty code 174400000X (174400000X); Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-12-08
- NPI last updated
- 2015-01-08
This is when the NPI record was last certified, not a medical board exam.